IL-5 Inhibitor Treatment in Drug Reaction With Eosinophilia and Systemic Symptoms
This case series evaluates the safety and efficacy of IL-5 inhibition for the treatment of drug reaction with eosinophilia and systemic symptoms.
Related Articles
Metabolic Accelerator for Obesity-Related HFpEF
This randomized clinical trial evaluates if HU6, a controlled metabolic accelerator, reduces body weight, improves body composition, and increases exercise capacity in patients with obesity-related…
Apraxia of Eyelid Opening in Myasthenia Gravis
This case report describes a 61-year-old man with myasthenia gravis initially diagnosed with blepharospasm who was later found to have the nonparalytic disorder apraxia of…
What Parents Need to Know About Online Misinformation
This JAMA Pediatrics Patient Page describes how parents can help their children build media literacy skills to recognize online misinformation.
Cytisinicline for Smoking Cessation
This phase 3 replication randomized clinical trial reassesses the efficacy and tolerability of cytisinicline for smoking cessation and reducing nicotine craving.
Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System
This electronic health record–based, prognostic study compares routine clinical suicide risk assessment for prospectively predicting suicide attempt using stratified prevalence vs machine learning models in…
Termination of a Federal Infection Prevention Advisory Committee
This Viewpoint discusses the US Centers for Disease Control and Prevention’s Healthcare Infection Control Practices Advisory Committee and how its termination could affect infection prevention…
Peripheral Nerve Blocks for Hip Fractures
This JAMA Insights explores the use of different types of peripheral nerve blocks as an opioid-sparing pain strategy in the treatment of adults with hip…
CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy
This cohort study investigates if coronary computed tomography (CT) angiography is associated with better lifestyle behaviors, acceptance of preventive therapies, and improvement in risk factor…
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
This prespecified secondary analysis of a randomized clinical trial assesses the role of circulating tumor DNA in predicting progression-free and overall survival in patients with…
Asymptomatic Symmetrical Telangiectasia on Lower Extremities
A man in his 60s with a history of hypertension, hyperlipidemia, and coronary artery disease presented with symmetrical diffuse, reticulated telangiectatic macules covering the legs…
